Stepp D W, Kroll K, Feigl E O
Department of Physiology and Biophysics, University of Washington, Seattle 98195-7290, USA.
Am J Physiol. 1997 Sep;273(3 Pt 2):H1299-308. doi: 10.1152/ajpheart.1997.273.3.H1299.
Autoregulation is defined as the intrinsic ability of an organ to maintain constant flow in the face of changing perfusion pressure. The present study evaluated the role of several potential mediators of coronary autoregulation: interstitial adenosine, ATP-sensitive K+ (K+ATP) channels, and myocardial oxygen and carbon dioxide tensions as reflected by coronary venous oxygen and carbon dioxide tensions. The left main coronary artery was cannulated, and blood was perfused at controlled pressures in closed-chest dogs. Interstitial adenosine concentration was estimated from arterial and venous adenosine concentrations with a previously described mathematical model. Autoregulation of coronary blood flow was observed between 100 and 60 mmHg. Glibenclamide, an inhibitor of K+ATP channels, reduced coronary blood flow by 19% at each perfusion pressure, but autoregulation was preserved. After stepwise reductions in coronary pressure to values > or = 70 mmHg, adenosine concentrations did not increase above basal levels. Adenosine concentration was elevated at 60 mmHg, suggesting a role for adenosine at the limit of coronary autoregulation. Adenosine is not required because glibenclamide, an inhibitor of adenosine-mediated vasodilation, did not reduce autoregulation or increase adenosine concentration. Coronary venous oxygen and carbon dioxide tensions were little changed during autoregulation before the inhibition of K+ATP channels and adenosine vasodilation with glibenclamide. However, coronary venous carbon dioxide tension rose progressively with decreasing coronary pressure after glibenclamide. The increase in carbon dioxide indirectly suggests that carbon dioxide-mediated vasodilation compensated for the loss of K+ATP-channel function. In summary, neither K+ATP channels nor adenosine is necessary to maintain coronary flow in the autoregulatory range of coronary arterial pressure from 100 to 60 mmHg.
自动调节被定义为器官在面对灌注压力变化时维持恒定血流的内在能力。本研究评估了冠状动脉自动调节的几种潜在介质的作用:间质腺苷、ATP敏感性钾(K+ATP)通道,以及由冠状静脉氧和二氧化碳张力反映的心肌氧和二氧化碳张力。在开胸狗身上,将左冠状动脉主干插管,并在控制压力下进行血液灌注。用先前描述的数学模型根据动脉和静脉腺苷浓度估算间质腺苷浓度。在100至60 mmHg之间观察到冠状动脉血流的自动调节。格列本脲是一种K+ATP通道抑制剂,在每个灌注压力下使冠状动脉血流减少19%,但自动调节得以保留。在冠状动脉压力逐步降低至≥70 mmHg后,腺苷浓度未升高至基础水平以上。在60 mmHg时腺苷浓度升高,提示腺苷在冠状动脉自动调节极限时发挥作用。腺苷并非必需,因为作为腺苷介导的血管舒张抑制剂的格列本脲并未降低自动调节或增加腺苷浓度。在用格列本脲抑制K+ATP通道和腺苷血管舒张之前,自动调节期间冠状静脉氧和二氧化碳张力变化不大。然而,在用格列本脲处理后,随着冠状动脉压力降低,冠状静脉二氧化碳张力逐渐升高。二氧化碳的增加间接表明二氧化碳介导的血管舒张补偿了K+ATP通道功能的丧失。总之,在冠状动脉压力从100至60 mmHg的自动调节范围内,维持冠状动脉血流既不需要K+ATP通道也不需要腺苷。